Huntington disease: New insights into the relationship between CAG expansion and disease

Human Molecular Genetics

Volumn 5, Issue REVIEW, 1996, Pages 1431-1435

  Nasir, Jamal ^a   Goldberg, Y Paul ^a   Hayden, Michael R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYSTEINE PROTEINASE;

APOPTOSIS; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY; YEAST ARTIFICIAL CHROMOSOME;

EID: 0029791355     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/5.supplement_1.1431     Document Type: Short Survey

References (48)

1. Huntington's Disease Collaborative Research Group. (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
2. Sharp, A., Loev, S.J., Schilling, G., Li, S.H., Li, X.J., Bao, J., Wagster, M.V., Kotszuk, J.A., Steiner J.P., Lo, A., Hedreen, J., Sisodia, S., Snyder, S.H., Dawson, T.M., Ryugo, D.K. and Ross, C.A. (1995) Widespread expression of Huntington's disease gene (IT-15) protein product. Neuron 14, 1065-1074.
3. DiFiglia, M., Sapp, E., Chase, K., Schwarz, C. , Meloni, A., Young, C., Martin, E., Vonsattel, J.P., Carraway, R., Reeves, S.A., Boyce, F.M. and Aronin, N. (1995) Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14, 1075-1081.
4. Trottier, Y., Devys, D., Imbert, G., Saudou, F., An, I., Lutz, Y., Weber, C., Agid, Y., Hirsch, E.C. and Mandel, J-L. (1995) Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nature Genet. 10, 104-110.
5. Gutekunst, C-A., Levey, A.I., Heilman, C.J., Whaley, W.L., Yi, H., Nash, N.R., Rees, H.D., Madden, J.J. and Hersch, S.M. (1995) Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc. Natl Acad. Sci. USA 92, 8710-8714.
6. Jou, Y.S. and Myers, R.M. (1995) Evidence from antibody studies that the CAG repeat in the Huntington disease gene is expressed in the protein. Hum. Mol. Genet. 4, 465-469.
7. Housman, D. (1995) Gain of glutamines, gain of function? Nature Genet. 10, 3-4.
8. Goldberg, Y.P., Nicholson, D.W., Rasper, D.M., Kalchman, M.A., Koide, B., Graham, R.K., Bromm, M., Kazemi-Esfarjani, P., Thornberry, N.A., Vaillancourt, J.P. and Hayden, M.R. The polyglutamine tract in Huntingtin modulates its cleavage by CPP32/Apopain, a proapoptotic cystein protease. Nature Genet. (in press).
9. Li, X-J., Li, S-H., Sharp, A.H., Nucifora Jr., F.C., Schilling, G., Lanahan, A., Worley, P., Snyder, S.H. and Ross, C.A. (1995) A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378, 398-402.
10. Burke, J.R., Enghild, J.J., Margin, M.E., Joy, Y-S., Myers, R.M., Roses, A.D., Vance, J.M. and Strittmatter, W.J. (1996) Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Med. 2, 347-350.
11. Kalchman, M.A., Graham, R.K., Xia, G., Koide, H.B., Hodgson, J.G., Graham, K.C., Goldberg, Y.P., Gietz, R.D., Pickart, C.M. and Hayden, M.R. Huntingtin is ubiquitinated and interacts with a specific ubiquitin conjugated enzyme. J. Biol. Chem. (in press).
12. Goldberg, Y.P., Kalchman, M.A., Zeisler, J., Graham, R., Koide, H.B., O'Kusky, J., Sharp, A.H., Ross, C.A., Jirik, F. and Hayden, M.R. (1996) Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the Huntington disease transcript. Hum. Mol. Genet. 5, 177-185.
13. Trottier, Y., Lutz, Y., Stevanin, G., Imbert, G., Devys, D., Cancel, G., Weber, C., Saudou, F., David, G., Tora, L., Agid, Y., Brice, A. and Mandel, J-L. (1995) Polyglutamine expansion as a common pathological epitope detected in Huntington's disease, in spinocerebellar ataxia 1 and 3 and two additional autosomal dominant cerebellar ataxias. Nature 378, 403-406.
14. Burright, E.N., Clark, H.B., Servadio, A., Matilla, T., Feddersen, R.M., Yunis, W.S., Duvick, L.A., Zoghbi, H.Y. and Orr, H.T. (1995) SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell 82, 937-948.
15. Nasir, J., Floresco, S.B., O'Kusky, J.R., Diewert, V.M., Richman, J.M., Zeisler, J., Borowski, A., Marth, J.D., Phillips, A.G. and Hayden, M.R. (1995) Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81, 811-823.
16. Duyao, M.P., Auerbach, A.B., Ryan, A., Persichetti, F., Barnes, G.T., McNeil, S.M., Ge, P., Vonsattel, J-P., Gusella, J.F., Joyner, A.L. and MacDonald, M.E. (1995) Inactivation of the Mouse Huntington's Disease Gene Homolog Hdh. Science 269, 407-410.
17. Zeitlin, S., Liu, J-P., Chapman, D.L., Papaioannou, V.E. and Efstratiadis, A. (1995). Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nature Genet. 11, 155-162.
18. Myers, R.H., Leavitt, J., Karner, L.A., Farrer, L., Jagedeesh, J., McFarlane, H., Mastromouro, C.A., Mark, R.J. and Gusella, J.F. (1989) Homozygote for Huntington disease. Am. J. Hum. Genet. 45, 615-618.
19. Wexler, N.S., Young, A.B., Tanzi, R.E., Travers, H., Starosta-Rubenstein, S., Penney, J.B., Snodgrass, S.R., Shoulson, I., Gomez, F., Ramos-Arroyo, M.A., Penchaszadeh, G., Moreno, R., Gibbons, K., Faryniarz, A., Hobbs, W., Anderson, M.A., Bonilla, E., Conneally, P.M. and Gusella, J.F. (1987) Homozygotes for Huntington disease. Nature 326, 194-197.
20. La Spada, A.R., Roling, D.B., Darding, A.E., Warner, C.L., Spiege, R., Hausmanowa-Petrusewicz, I., Yee, W-C. and Fishback KH. (1992) Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nature Genet. 2, 301-304.
21. Thomas, L.B., Gates, D.J., Richfield, E.K., O'Brien, T.F., Schweitzer, J.B. and Steindler, D.A. (1995) DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp. Neurol. 133, 265-272.
22. Dragunow, M., Faull, R.L.M., Lawlor, P., Beilhartz, E.J., Singleton, K., Walker, E.B. and Mee, E. (1995) In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Clin. Neurosci. Neuropathol. 6, 1053-1057.
23. Protera-Cailliau, C., Hedreen, J.C., Price, D.L. and Koliatsos, V.E. (1995) Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neurosci. 15, 3775-3787.
24. Yuan, J-Y., Shaham, S., Ledoux, S., Ellis, H.J.M. and Horvitz, H.R. (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 75, 641-652.
25. Nicholson, D.W., Ali, A., Thornberry, N.A., Vaillancourt, J.P., Ding, C.K., Gallant, M., Gareau, Y., Griffin, P.R., Labelle, M., Lazebnik, Y.A., Munday, N.A., Raju, S.M., Smulson, M.E., Yamin, T-T., Yu, V.L. and Miller, D.K. (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376, 37-43.
26. Tewari, M., Quan, L.T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D.R., Poirier, G.G., Salvesen, G.S. and Dixit, V.M. (1995) Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81, 801-809.
27. Gerber, H.P., Seipel, K., Georgiev, O., Hofferer, M., Hug, M., Rusconi, S. and Schaffner, W. (1994) Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science 263, 808-811.
28. Wang, X., Zelenski, N.G., Yang, J., Sakai, J., Brown, M.S. and Goldstein, J.L. (1996) Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis. EMBO J. 15, 1012-1020.
29. Li, X-J., Sharp, A.H., Li, S-H., Dawson, T.M., Snyder, S.H. and Ross, C.A. (1996) Huntingtin-associated protein (HAP1): Discrete neuronal localizations in the brain resemble those of neuronal nitric oxide synthase. Proc. Natl Acad. Sci. USA 93, 4839-4844.
30. Hayden, M.R., Hewitt, J., Stoessl, J., Clark, C., Moennich, D. and Martin, W. The combined use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington disease. Neurology 37, 1441-1447.
31. Grafton, S.T., Mazziotta, J.C., Pahl, J.J., St. George-Hyslop, P., Haines, J., Gusella, J., Hoffman, J.M., Baxter, L.R., Phelps, M.E. (1992) Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington Disease. Arch. Neurol. 49, 1161-1167.
32. Schulze, H., Schuler, A., Stüber, Döbeli, H., Langen, H. and Huber, G. (1993) Rat brain glyceraldehyde-3-phosphate dehydrogenase interacts with the recombinant cytoplasmic domain of Alzheimer's β-amyloid precursor protein. J. Neurochem. 60, 1915-1992.
33. Ishitani, R., Sunaga, K., Hirano, A., Saunders, P., Katsube, N. and Chuang, D-M. (1996) Evidence that glyceraldehyde-3-phosphate dehydrogenase is involved in age-induced apoptosis in mature cerebellar neurons in culture. J. Neurochem. 66, 928-935.
34. Chen, Z., Niles, E.G. and Pickart, C.M. (1991) Isolation of a cDNA encoding a mammalian multiubiquitinating enzyme (E225K) and overexpression of the functional enzyme in Escherichia coli. J. Biol. Chem. 266, 15698-15704.
35. Deshaies, R.J. (1995) Make it or break it: the role of ubiquitin-dependent proteolysis in cellular regulation. Trends Cell Biol. 5, 428-434.
36. Cammarata, S., Caponnetto, C. and Tabaton, M. (1993) Ubiquitin-reactive neurites in cerebral cortex of subjects with Huntington's chorea: a pathological correlate of dementia? Neurosci. Lett. 156, 96-98.
37. Taddei, N., Liguri, G., Sorbi, S., Amaducci, L., Camici, G., Nassi, P., Cecchi, C. and Ramponi, G. (1993) Cerebral soluble ubiquitin is increased in patients with Alzheimer's disease. Neurosci. Lett. 151, 158-161.
38. Sigiyama, H., Hainfeller, J.A., Yoshimura, M. and Budka, H. (1994) Neocortical changes in Parkinson's disease, revisited. Clin. Neuropathol. 13, 55-59.
39. Schiffer, D., Attanasino, A., Chio, A., Migheli, A. and Pezzulo, T. (1994) Ubiquitinated dystrophic neurites suggest corticospinal derangement in patients with amyotrophic lateral sclerosis. Neurosci. Lett. 180, 21-24 .
40. Bao, J., Sharp, A.H., Wagster, M.V., Becher, M., Schilling, G., Ross, C.A., Dawson, V.L. and Dawson, T.M. (1996) Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Proc. Natl Acad. Sci. USA 93, 5037-5042.
41. Baunez, C., Nieoullon, A. and Amalric, M. (1995) In a rat model of parkinsonism, lesions of the subthalamic nucleus reverse increases of reaction time but induces a dramatic premature responding deficit. J. Neurosci. 15, 6531-6541.
42. Parent, A. and Hazrati, L-N. (1995) Functional anatomy of the basal ganglia II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res. Rev. 20, 128-154.
43. Schmidt, E.V., Christoph, G., Zeller, R. and Leder, P. (1990) The cytomegalovirus enhancer: a pan-active control element in transgenic mice. Mol. Cell. Biol. 10, 4406-4411.
44. Sauerwald, A., Hoesche, C., Oschwald, R. and Kilimann, M.W. (1990) The 5'-flanking region of the synapsin I gene: A G+C-rich, TATA- and CAAT-less, phylogenetically conserved sequence with cell type-specific promoter function. J. Biol. Chem. 265, 14932-14937.
45. Alouani, S., Ketchum, S., Rambosson, C. and Eistetter, H.R. (1993) Transcriptional activity of the neuron-specific enolase (NSE) promoter in murine embryonic stem (ES) cells and preimplantation embryos. Eur. J. Cell Biol. 62, 324-332.
46. Rinco'n-Limas, D.E., Geske, R.S., Xue, J-J., Hus, C.Y., Overbeek, P.A. and Patel, P.I. (1994) 5′-flanking sequences of the human HPRT gene direct neuronal expression in the brain of transgenic mice. J. Neurosci. Res. 38, 259-267.
47. Duff, K., McGuigan, A., Huxley, C., Schulz, F. and Hardy, J. (1994) Insertion of a pathogenic mutation into a yeast artificial chromosome containing the human amyloid precursor protein gene. Gene Ther. 1, 70-75.
48. Orban, P.C., Chui, D. and Marth, J.D. (1992) Tissue- and site-specific DNA recombination in transgenic mice. Proc. Natl Acad. Sci. USA 89, 6861-6865.